MedAssets Receives Consensus Rating of “Buy” from Analysts (NASDAQ:MDAS)
Shares of MedAssets (NASDAQ:MDAS) have received an average rating of “Buy” from the twenty ratings firms that are presently covering the stock, Analyst Ratings Net reports. Nine equities research analysts have rated the stock with a hold recommendation, nine have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month target price among brokerages that have updated their coverage on the stock in the last year is $25.77.
Shares of MedAssets (NASDAQ:MDAS) traded down 0.67% during mid-day trading on Tuesday, hitting $23.64. The stock had a trading volume of 23,942 shares. MedAssets has a 52-week low of $16.31 and a 52-week high of $26.58. The stock has a 50-day moving average of $24.10 and a 200-day moving average of $22.7. The company has a market cap of $1.460 billion and a P/E ratio of 52.89.
MedAssets (NASDAQ:MDAS) last announced its earnings results on Wednesday, February 26th. The company reported $0.30 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.28 by $0.02. The company had revenue of $170.50 million for the quarter, compared to the consensus estimate of $165.64 million. During the same quarter last year, the company posted $0.27 earnings per share. MedAssets’s revenue was up 4.1% compared to the same quarter last year. Analysts expect that MedAssets will post $1.39 EPS for the current fiscal year.
Several analysts have recently commented on the stock. Analysts at RBC Capital raised their price target on shares of MedAssets from $21.00 to $25.00 in a research note on Monday. Separately, analysts at Barclays initiated coverage on shares of MedAssets in a research note on Wednesday, March 5th. They set an “equal weight” rating and a $23.00 price target on the stock. Finally, analysts at First Analysis downgraded shares of MedAssets from an “overweight” rating to an “equal weight” rating in a research note on Tuesday, March 4th.
MedAssets, Inc (NASDAQ:MDAS) provides technology-enabled products and services.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.